US Executive Officer Management Changes SEC — August 19, 2026

19-08-2026

On August 17, 2026, Revelation Biosciences, Inc. granted restricted stock awards to CEO James Rolke (208,076 shares) and CFO Chester S. Zygmont III (208,073 shares) under the 2021 Equity Incentive Plan. The awards vest in four tranches tied to market capitalization milestones of $30M, $60M, $90M, and $120M, with time-based fallback vesting at two or four years. The grants are performance-based with no immediate cash compensation, but the vesting conditions are entirely market-cap driven, not operational metrics.

• · The restricted stock awards vest in four equal 25% tranches based on market capitalization milestones: $30M, $60M, $90M, and $120M, each sustained for 20 consecutive trading days.
• · Time-based fallback vesting occurs at the second anniversary for the first two tranches and the fourth anniversary for the last two tranches.
• · Full vesting accelerates upon a Change in Control, termination without Cause, by the executive for Good Reason, or death.
• · Unvested shares are forfeited upon termination for Cause, Disability, or Retirement.

19-08-2026

Granite Ridge Resources, Inc. announced that Grey Rock Investment Partners distributed 14,000,000 shares to limited partners, reducing its beneficial ownership to approximately 39% and ending the company's status as a "controlled company" under NYSE standards. The Board expanded from seven to nine members with the appointment of two independent directors, Jonathan Adams and John Cocke, creating a majority-independent board. While the distribution reflects positive governance progress, the company remains heavily reliant on Grey Rock, which continues as its largest shareholder and maintains existing service agreements; the company also anticipates an inflection to free cash flow in 2027, but no specific financial results or growth metrics were reported in this filing.

• · The share distribution was made in kind under an effective resale registration statement; it was not an underwritten offering and Granite Ridge received no proceeds.
• · The total number of shares outstanding was unchanged by the distribution; Granite Ridge did not issue any new shares.
• · The company expects to complete its transition to a non-controlled governance structure within NYSE phase-in periods.
• · Grey Rock's Master Services Agreement and the agreements governing Operated Partnerships remain unchanged.
• · Granite Ridge anticipates an inflection to free cash flow in 2027.
• · Mr. Adams is a CFA charterholder and licensed CPA in Texas; Mr. Cocke is also a CFA charterholder.

19-08-2026

LCNB Corp. announced the appointment of Susan B. Zaunbrecher to its Board of Directors and the Board of LCNB National Bank, effective immediately. Zaunbrecher brings over 30 years of legal, financial services, and corporate governance experience, most recently as Chief Legal Officer and Corporate Secretary of Fifth Third Bancorp. The appointment is part of LCNB's ongoing strategy to strengthen its board with experienced leadership.

• · Zaunbrecher recently retired as Chief Legal Officer and Corporate Secretary of Fifth Third Bancorp, a Fortune 500 institution.
• · She is the first woman to chair Dinsmore's Corporate Department and served on its Board of Directors and Executive Committee for nearly 20 years.
• · She earned her J.D. from the University of Cincinnati College of Law and her B.A. from Newcomb College of Tulane University.
• · LCNB Corp. common shares are traded on the NASDAQ Capital Market Exchange under the symbol LCNB.

19-08-2026

MediciNova entered into new Executive Employment Agreements with CEO Yuichi Iwaki and CMO Kazuko Matsuda on August 17, 2026, superseding prior arrangements. The agreements set base salaries of $690,246 for Dr. Iwaki and $540,143 for Dr. Matsuda, with target bonuses of 55% and 40% of base salary, respectively, and provide enhanced severance benefits including up to 24 months of salary and bonus plus full equity acceleration in change-of-control scenarios. No financial results or period-over-period comparisons are included in this filing.

• · Severance for both executives includes 12 months of base salary and COBRA coverage for involuntary termination not related to a change in control.
• · In a change-of-control termination, CEO receives 24 months of base salary plus 24 months of target bonus, 18 months COBRA, and full equity acceleration; CMO receives 18 months of base salary plus 18 months of target bonus, 18 months COBRA, and full equity acceleration.
• · Agreements include a one-year post-termination non-solicitation covenant and customary Section 280G cutback provisions.
• · Employment is at-will and governed by Delaware law.

19-08-2026

AMD appointed Tim Ryan to its board of directors effective August 19, 2026, following the retirement of Joseph Householder after more than 11 years of service. Ryan brings deep expertise in technology, enterprise operations, and financial governance from his roles at Citi and PwC. The company also announced committee changes, with KC McClure named chair of the Audit and Finance Committee and Nora Denzel joining that committee.

• · Tim Ryan served as U.S. Chair and Senior Partner at PwC from 2016 to 2024 before joining Citi in 2024.
• · Ryan is a certified public accountant with a bachelor's degree in accounting and communications from Babson College.
• · KC McClure was also appointed to the Nominating and Corporate Governance Committee.
• · Nora Denzel, AMD's lead independent director, has joined the Audit and Finance Committee.

19-08-2026

Longeveron Inc. appointed Nirav Jhaveri, CFA, as Chief Financial Officer, principal financial officer, and principal accounting officer, effective August 19, 2026. He succeeds Marie Washburn, who will return to her former role as Corporate Controller. The company also highlighted that its Phase 2b clinical trial for laromestrocel in HLHS is anticipated to produce top-line results in September 2026.

• · Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development, and investor relations, including more than 15 years in the biotech sector.
• · He previously served as CFO of Opus Genetics, Insilico Medicine, and Journey Medical Corporation.
• · The Phase 2b trial for laromestrocel in HLHS is expected to produce top-line results in September 2026.
• · Laromestrocel has received five FDA designations: Orphan Drug, Fast Track, and Rare Pediatric Disease for HLHS; and RMAT and Fast Track for Alzheimer's disease.

19-08-2026

Ameresco announced that CFO Mark Chiplock will resign effective September 25, 2026, to take a CFO role at a private equity-owned company in a different industry. The company reiterated its full-year 2026 guidance with revenue of $2.0B to $2.2B, Adjusted EBITDA of $250M to $270M, and Non-GAAP EPS of $1.15 to $1.35. A search for a new CFO has begun.

• · CFO Mark Chiplock will continue in his role through September 25, 2026, to ensure an orderly transition.
• · The company has begun a search for a new CFO.
• · Ameresco has delivered over $15 billion in solutions and contracted over 5 GW of energy resources since its founding in 2000.

19-08-2026

Zhak Cohen, a GPC Fund nominee to the Board of Bowhead Specialty Holdings Inc., resigned effective August 17, 2026, in connection with his departure from Gallatin Point Capital LLC. The resignation was not due to any disagreement with the company on operations, policies, or practices.

• · Resignation effective August 17, 2026
• · Zhak Cohen was a nominee of GPC Fund to the Board under a Board Nominee Agreement dated May 23, 2024
• · Resignation related to Cohen's departure from Gallatin Point Capital LLC earlier in summer 2026
• · No disagreement with the company on operations, policies, or practices

19-08-2026

AVAX One Technology Ltd. announced the departure of CFO Chris Polimeni effective August 17, 2026, and the promotion of Controller Stephanie Brady to Chief Accounting Officer to oversee financial reporting. The Board continues its search for a permanent CEO with the help of executive search firm ZRG Partners. The filing notes no disagreement with the company's operations, policies, or practices as the reason for the CFO's departure.

• · Chris Polimeni has agreed to remain available through a consultancy arrangement to ensure a smooth transition.
• · Pete Wylie, Interim CEO and COO, brings prior CFO experience and will support the finance organization during the transition.
• · The Board's search for a permanent CEO is ongoing with global executive search firm ZRG Partners.

19-08-2026

Louise Goeser, a member of the Board of Directors of MSC Industrial Direct Co., Inc., notified the company on August 13, 2026, that she will not stand for re-election at the 2027 Annual Meeting of Shareholders as part of her retirement planning. The company stated her decision is not due to any disagreements with its operations, policies, or practices.

• · The departure is effective at the 2027 Annual Meeting of Shareholders.
• · Ms. Goeser's decision is part of her retirement planning and not due to any disagreements with the company.

19-08-2026

Laird Superfood, Inc. appointed Matthew Spanjers as a director and to its compensation committee, effective August 13, 2026. Mr. Spanjers brings extensive experience from senior roles at Krispy Kreme, McKinsey & Company, and other food companies, and is a designee of Nexus Capital Management LP under an existing Investment Agreement. The filing contains no financial results or period-over-period comparisons.

• · Mr. Spanjers (50) holds a B.A. in English Literature from Yale University and an MBA from Stanford Graduate School of Business.
• · He will receive cash compensation under the company's non-employee director compensation program and a grant of options vesting in equal annual installments over four years.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist between the company and Mr. Spanjers or his immediate family.

19-08-2026

On August 13, 2026, PDS Biotechnology Corp CFO Lars Boesgaard resigned effective September 12, 2026, to pursue other opportunities, with no disagreement with company policies. The board appointed Controller Janetta Trochimiuk as interim Principal Accounting Officer and CEO Frank Bedu-Addo as interim Principal Financial Officer, effective September 12, 2026. Ms. Trochimiuk retains her $279,519.57 annual base salary and equity award eligibility.

• · CFO resignation and appointment of interim officers effective September 12, 2026.
• · Ms. Trochimiuk has over 25 years of experience as Controller or CFO and is a licensed CPA.
• · No equity awards were granted to Ms. Trochimiuk in connection with her promotion.
• · No family relationships exist between Ms. Trochimiuk and any director or executive officer.

19-08-2026

Sera Prognostics appointed Scott Gleason as CFO effective August 31, 2026, bringing over 25 years of healthcare and diagnostics experience. Outgoing CFO Austin Aerts will transition to an advisory role focused on strategic initiatives. The change is a routine leadership transition with no financial results or regulatory action involved.

• · Scott Gleason previously served as VP of Investor Relations and Treasury at Neogen Corporation, CFO of LarmorBio and NX Prenatal, and interim CFO of OraSure Technologies.
• · Austin Aerts served as CFO since June 2023 and has been with Sera since 2017.
• · The PreTRM Test is the only broadly validated, commercially available blood-based biomarker test for preterm birth risk prediction.
• · U.S. preterm birth rate earned a D+ grade for the fourth consecutive year in the 2025 March of Dimes Report Card.
• · Annual healthcare costs for prematurity complications in the U.S. were estimated at approximately $25 billion for 2016.

19-08-2026

Neuraxis, Inc. (NRXS) completed a Stock Option Exchange on July 24, 2026, canceling 1,319,394 outstanding stock options and issuing an equivalent number of immediately vesting RSUs to executives, including CEO Brian Carrico (199,188 RSUs), CMO Adrian Miranda (199,106 RSUs), and CRO Thomas Carrico (193,678 RSUs). On August 13, 2026, the Compensation Committee granted additional time-vesting RSUs to executives (Brian Carrico: 193,329; CFO Timothy Henrichs: 141,479; Adrian Miranda: 133,341; Thomas Carrico: 135,906) and one-time equity awards totaling 127,120 shares to independent directors to address below-market historical compensation. The filing does not disclose any financial results or operational metrics, so no period-over-period comparisons are available.

• · The Stock Option Exchange was approved by stockholders on June 10, 2026, and became effective July 24, 2026.
• · All RSUs from the Stock Option Exchange vest immediately.
• · The additional RSUs granted on August 13, 2026, vest in three equal annual installments over three years.
• · The one-time equity awards to independent directors were based on a review by an independent compensation consultant and intended to address historical compensation below market levels.

19-08-2026

Michael Kahn has resigned from the Board of Directors of Internet Sciences Inc., effective August 14, 2026. The resignation was confirmed via email and is disclosed in an SEC 8-K filing. No reasons for the departure were provided in the filing.

• · The resignation was effective immediately as of August 14, 2026.
• · The filing does not disclose any reason for the resignation or any disagreements with the company.

19-08-2026

Encore Capital Group appointed Robert W. Beck to its board of directors, effective immediately. Beck brings over 30 years of financial services experience, including as former CEO of Regional Management Corporation and senior roles at Citigroup. He will serve on the Audit and Risk Committees, and the appointment is seen as aligning with the company's focus on maximizing shareholder value.

• · Beck will serve on the Board's Audit and Risk Committees.
• · Encore is a component of the Russell 2000, S&P Small Cap 600, and Wilshire 4500 indices.

19-08-2026

Unity Software Inc. granted CEO Matthew Bromberg a special award of 880,000 performance-based, price-vesting restricted stock units (PPSUs) on August 17, 2026. The award is entirely at-risk, vesting over a five-year period only if specific stock price hurdles ($50, $60, $75) are met and sustained, alongside continued service requirements. The Compensation Committee designed the grant to align CEO incentives with long-term stockholder value creation, focusing on the company's AI-driven platform integration and profitability goals.

• · The PPSUs are issued under Unity's 2020 Equity Incentive Plan.
• · Stock price hurdles for vesting: $50.00 (tranche 1), $60.00 (tranche 2), $75.00 (tranche 3).
• · Each stock price hurdle must be met by a 30-consecutive-day VWAP requirement.
• · Continued service requirements: CEO must remain in role until August 17, 2027 (tranche 1), August 17, 2028 (tranche 2), and August 17, 2029 (tranche 3).
• · Upon involuntary termination without Cause (outside Change in Control period), unvested PPSUs may vest if the stock price hurdle was met and the CEO would have satisfied the service requirement within 12 months.
• · Upon death or disability, unvested PPSUs remain eligible to vest for six months post-termination if stock price hurdles are achieved.
• · In a Change in Control, PPSUs may vest based on the transaction price per share, using linear interpolation between hurdles.
• · The award is a one-time, supplemental grant additive to the company's annual equity program.

19-08-2026

SHF Holdings, Inc. adopted an amended and restated Retention Plan and Retention Agreement on August 14, 2026, which makes directors ineligible for retention incentives and removes Change in Control compensation for shareholder-approved liquidations. The Board also canceled all prior director retention agreements ab initio. The amendments narrow the scope of retention benefits to employees only and tighten governance around insolvency determinations.

• · Directors are now ineligible for Retention Incentives under the A&R Retention Plan.
• · A determination of Insolvency by the CEO must be approved by the Board.
• · The definition of 'Change in Control' was amended to exclude shareholder-approved liquidation of substantially all net assets.
• · All prior director retention agreements were canceled ab initio.
• · Eligible employees may receive a Retention Incentive equal to a designated percentage of base salary upon a Change in Control, and a base salary increase during Insolvency, subject to a general release of claims.

19-08-2026

Envista Holdings Corp announced the appointment of President and CEO Paul Keel as Chairman of the Board, effective August 19, 2026, succeeding Scott Huennekens who will remain as Lead Independent Director. Concurrently, the Compensation Committee approved significant compensation changes for Mr. Keel, including a $200,000 base salary increase (from $1.1M to $1.3M) and a special one-time equity award valued at $10 million, as well as a $1.5 million special PSU award for CFO Eric Hammes. These changes are designed to retain key executives and align incentives with long-term stockholder value creation.

• · The RSUs vest over four years with 25% vesting on each one-year anniversary of the grant date (August 18, 2026).
• · The PSUs vest based on the Company's four-year TSR percentile rank relative to the S&P 400 Health Care Sector Index, with the performance period starting August 18, 2026.
• · All equity awards are granted under the Envista Holdings Corporation 2019 Omnibus Incentive Plan, as amended.
• · Scott Huennekens will continue to serve as a director and as Lead Independent Director following the board leadership transition.

19-08-2026

Baxter International Inc. announced the appointment of John Rogers as EVP and CFO, effective October 1, 2026, succeeding the current CFO. Rogers brings extensive transformation and leadership experience from Smith+Nephew, WPP, and Sainsbury's. The company also reiterated its full-year 2026 financial outlook, indicating no change in guidance.

• · John Rogers previously served as CFO of Smith+Nephew plc since 2024 and as CFO of WPP plc.
• · Rogers holds a master's degree in electrical engineering from Imperial College London, an MBA from INSEAD, and completed the Advanced Management Program at Harvard Business School.
• · Baxter reiterated its full-year 2026 financial outlook as provided on July 30, 2026.
• · The company has approximately 37,500 employees.

19-08-2026

Core Natural Resources (CNR) announced a long-planned executive succession: President Mitesh Thakkar assumes expanded day-to-day responsibility for operations, marketing, logistics, and strategy, while Nathan Tucker is elected Senior Vice President and CFO, effective immediately. The changes reflect the company's ongoing leadership development following its formation in January 2025 via the merger of CONSOL Energy and Arch Resources. No financial metrics or performance comparisons were provided in this filing.

• · Thakkar had served as President and CFO since the company's formation in January 2025; prior to that, he was SVP and CFO of CONSOL Energy since 2020.
• · Tucker had served as Vice President of Finance since the company's formation; prior to that, he was Director of Finance and Investor Relations for CONSOL from 2020.
• · The company operates large-scale longwall mines (Pennsylvania Mining Complex, Leer, Leer South, West Elk) and the Black Thunder surface mine, with ownership in two East Coast marine export terminals.

19-08-2026

United Community Banks (UCB) announced the appointment of Tom Speir as Executive Vice President and Chief Financial Officer, effective September 8, 2026. Speir brings over two decades of experience in balance sheet management, M&A, strategic planning, and investor relations. He succeeds Jefferson Harralson, who announced his retirement earlier this year.

• · Tom Speir will join the bank on September 8, 2026.
• · Speir succeeds Jefferson Harralson, who announced his retirement earlier in 2026.
• · Speir's experience includes balance sheet management, M&A, strategic planning, and investor relations.

19-08-2026

Honeywell Technologies announced leadership changes effective October 1, 2026: Billal Hammoud will become President and CEO of Process Technology, succeeding Ken West who is leaving the company. Juan Picon will succeed Hammoud as President and CEO of Building Automation. Hammoud previously led Building Automation, accelerating its annual organic growth from 2% in 2023 to 8% in 2025, while the company also highlighted its $4.95 billion acquisition of Access Solutions.

• · Ken West is leaving the company as of August 31, 2026 to pursue an external opportunity.
• · Hammoud led Building Automation to seven consecutive quarters of high-single-digit organic growth and margin expansion.
• · Juan Picon received the company's annual Chairman's Award in 2025.
• · Picon holds an MBA from Arizona State University, a master's degree in European Union Law from the University of Carlos III of Madrid, and a Law degree from the University Complutense of Madrid.
• · Hammoud holds an MBA and a B.S. degree in Mechanical Engineering from Wayne State University.

19-08-2026

Herc Holdings Inc. announced the election of Erik Olsson to its Board of Directors, effective August 18, 2026. Mr. Olsson, former Chairman, President and CEO of Mobile Mini and former President and CEO of RSC Holdings, will serve as an independent director and on the Audit Committee. He will receive prorated compensation under the non-employee director program and enter into a standard indemnification agreement.

• · Mr. Olsson will serve as a member of the Audit Committee.
• · His annual cash retainer and equity award will be prorated for his initial term of service.
• · He will enter into an Indemnification Agreement with the Company with substantially the same provisions as those for existing directors.

19-08-2026

NACCO Industries appointed Patrick J. Burns as an independent director effective August 19, 2026. Mr. Burns brings over 30 years of executive leadership experience, including roles as CEO and CFO at manufacturing and industrial companies. The appointment adds financial and strategic expertise to the Board.

• · Mr. Burns served as CEO of Precision Fabrics Group from 2022 to July 2026.
• · He was formerly President and CEO of AGY Holdings Corp.
• · He holds a BA in Economics from Vanderbilt University and an MBA from UNC Chapel Hill.

19-08-2026

Freddie Deutsch, Director of Specialty Business Lending of First Community Bank, has notified the company of his voluntary retirement effective January 15, 2027. Under a letter amendment, he will serve in an advisory role during the transition, receive the first $50,000 installment of his retention bonus plus a $100,000 carve-back payment, and forfeit the remaining retention installments and unvested equity (2,500 restricted shares). The company faces succession risk but Deutsch's departure is not related to any disagreement or the previously announced management transition.

• · Retirement is effective January 15, 2027 (Retirement Date).
• · Letter Amendment conditioned on execution of a general release of claims.
• · During transition period, Deutsch serves in advisory role and no longer as Director of Specialty Business Lending.
• · Base salary and benefits remain unchanged during transition.
• · Unvested restricted stock (2,500 shares, with vesting date January 8, 2029) forfeited upon retirement.
• · COBRA coverage with Bank-subsidized premiums for 18 months post-retirement; marketplace alternative with equivalent monthly reimbursement available.
• · All restrictive covenants (confidentiality, non-solicitation, non-competition) remain in full force and effect after retirement.
• · The retirement is voluntary and not related to any disagreement or the previously announced management succession/leadership transition (July 22, 2026).
• · Deutsch joined the Company in connection with the acquisition of Signature Bank of Georgia (completed January 8, 2026).

19-08-2026

Microchip Technology held its 2026 annual meeting on August 18, 2026, where all eight director nominees were elected and three proposals were approved by stockholders. The approved proposals include an amendment to the 2004 Equity Incentive Plan to increase authorized shares by 12,000,000, ratification of Ernst & Young as independent auditor for fiscal year ending March 31, 2027, and advisory approval of named executive officer compensation. Notably, director Ellen L. Barker received the highest number of votes against (58,930,857) among nominees, and the advisory say-on-pay proposal had 17.4% votes against, indicating some shareholder dissent.

• · All director nominees were elected with votes for ranging from 386,259,649 to 439,287,679.
• · Ellen L. Barker received 58,930,857 votes against, the highest among nominees.
• · The amendment to the equity plan was approved with 430,844,377 votes for and 13,783,474 against.
• · Ratification of Ernst & Young as auditor was approved with 448,748,959 votes for and 32,630,529 against.
• · Advisory say-on-pay was approved with 366,406,303 votes for and 77,323,079 against (17.4% against).
• · Broker non-votes were 36,264,971 for all proposals except the auditor ratification (which had no broker non-votes).